Gene Therapy and Molecular Immunology Unite to Give New Life to Cancer Immunotherapy
Open Access
- 30 June 2002
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 5 (6) , 665-667
- https://doi.org/10.1006/mthe.2002.0616
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- GM-CSF-based cellular vaccines: a review of the clinical experienceCytokine & Growth Factor Reviews, 2001
- Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantationTransplantation and Cellular Therapy, 2001
- Cytokine-secreting tumor cell vaccinesCurrent Opinion in Immunology, 2000
- Cancer vaccinesNature Medicine, 1998
- Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA–liposome complexesProceedings of the National Academy of Sciences, 1996
- Is cancer dangerous to the immune system?Seminars in Immunology, 1996
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.Journal of Clinical Oncology, 1995
- Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Proceedings of the National Academy of Sciences, 1993
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- VIRAL ONCOLYSIS: INCREASED IMMUNOGENICITY OF HOST CELL ANTIGEN ASSOCIATED WITH INFLUENZA VIRUSThe Journal of Experimental Medicine, 1967